GSK responds to Senate report on Avandia

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) issued a white paper in response to a Senate Finance Committee report questioning the safety of diabetes drug Avandia rosiglitazone. GSK states in the paper tha...